Paperonium

← Back to the plain-language case

Abstract and Table 3 give a myocardial infarction confidence interval that excludes its own estimate

Diabetes Care (2009) · doi:10.2337/dc09-1297 · PMC2782995

Summary

The abstract and Table 3 report the ratio of relative risks (RRs) of aspirin for myocardial infarction (MI), in patients with diabetes versus without, as 1.19 with a 95% CI of 0.82–1.17. The upper limit, 1.17, is below the point estimate, 1.19, so the interval cannot be right as printed. The paper's stated Altman–Bland method, applied to the subgroup RRs printed in the same table, gives 1.19 (95% CI 0.82–1.73), P = 0.35. The same calculation reproduces the mortality and ischemic stroke rows exactly. The corrected interval still includes 1, so the paper's conclusion of no significant interaction stands. But the printed interval is about half as wide as it should be on the log scale, and it makes a headline result look much more precise than the data allow. The 2018 erratum to this article does not address the interval.

What the paper reports

Abstract, Results:

The ratios of RRs comparing the benefit of aspirin among patients with diabetes compared with patients without diabetes for mortality, myocardial infarction, and ischemic stroke were 1.12 (95% CI 0.92–1.35), 1.19 (0.82–1.17), and 0.70 (0.25–1.97), respectively.

Table 3, "Aspirin-diabetes subgroup interaction analyses", MI row. The columns are RR with diabetes | RR without diabetes | P interaction | Ratio of RRs pooled across trials† | Ratio of RRs pooled within trials‡ | Ratio of RRs Bayesian analyses§:

Myocardial infarction | 0.86 (0.67–1.11) | 0.72 (0.55–0.95) | 0.36 | 1.19 (0.82–1.17) | 1.02 (0.71–1.47) | 1.06 (0.16–6.71)

Table 3, footnote † (the column that holds the error):

Ratios of RRs in this method are pooled across randomized controlled trials and subgroups of randomized controlled trials of patients with diabetes versus without diabetes; then a ratio of pooled estimates is estimated. Numbers in parentheses represent 95% CIs, which indicate a significant interaction if it excludes 1.

Research Design and Methods, "Interaction between the effect of aspirin and diabetes status":

First, we estimated the ratio of RRs and its 95% CI using the method of Altman and Bland (13). This estimate compares the pooled RRs across subgroups of patients with diabetes and without across trials.

Results, "Prevention of cardiovascular events with aspirin" (the subgroup RRs that feed the ratio):

Estimates among patients with diabetes were 0.97 (0.87–1.08; I2 0%), 0.86 (0.67–1.11; I2 53%), and 0.62 (0.31–1.24; I2 67%), respectively. The corresponding estimates among patients without diabetes were 0.87 (0.75–1.02; I2 0%), 0.72 (0.55–0.95; I2 70%), and 0.89 (0.41–1.94; I2 0%), respectively.

Abstract, Conclusions:

Whereas estimates of benefit among patients with diabetes remain imprecise, our analysis suggests that the relative benefit of aspirin is similar in patients with and without diabetes.

What the paper's own numbers show

Method. Altman and Bland (BMJ 2003;326:219) compare two independent estimates on the log scale. The ratio is RR₁/RR₂, and SE(ln ratio) = √(SE₁² + SE₂²), where each SE comes from its published 95% CI as (ln upper − ln lower)/(2 × 1.96). I applied this to the "RR with diabetes" and "RR without diabetes" columns of Table 3 for all three outcomes. As cross-checks, I also computed (a) the upper limit that is log-symmetric with the printed lower limit about the printed point, (b) the interval implied by the printed P interaction, and (c) the ratio from the MI subgroup subtotals in the corrected Fig. 2B published in the 2018 erratum. Every number below is printed by recompute.py.txt.

Quantity Location Reported Recomputed
MI ratio of RRs, point Abstract; Table 3, across-trials column 1.19 1.194 (0.86/0.72)
MI ratio of RRs, 95% CI Abstract; Table 3, across-trials column 0.82–1.17 0.82–1.73 (0.823–1.733)
MI two-sided P for the ratio Table 3, P interaction 0.36 0.35
MI SE(ln ratio) derived 0.091 (implied by 0.82–1.17) 0.190
Log-scale midpoint of the printed MI CI derived should equal the point, 1.19 0.979
Upper limit log-symmetric to printed 0.82 about 1.19 derived — 1.727
95% CI implied by printed P = 0.36 and point 1.19 derived — 0.82–1.73
MI ratio from 2018 erratum Fig. 2B subtotals, 0.85 (0.66–1.10) and 0.72 (0.55–0.94) Erratum, Fig. 2B "Subgroup interaction: p=0.38" 1.181 (0.815–1.709), p = 0.38
Mortality ratio of RRs (control row) Abstract; Table 3 1.12 (0.92–1.35), P = 0.28 1.115 (0.924–1.345), p = 0.26
Ischemic stroke ratio of RRs (control row) Abstract; Table 3 0.70 (0.25–1.97), P = 0.50 0.697 (0.246–1.974), p = 0.50

Applied to the paper's own inputs, the method reproduces both control rows to the printed precision. (The mortality point, 0.97/0.87 = 1.1149, sits on the rounding boundary between 1.11 and 1.12. The small P differences fit with recomputing from rounded inputs.) For MI it reproduces the point estimate (1.19), the lower limit (0.82) and the P value (0.35 vs 0.36). Only the upper limit fails, at 1.73 against the printed 1.17. Three independent routes all put the upper limit between 1.71 and 1.73: log symmetry with the printed lower limit, the printed P value, and the erratum's corrected subtotals.

Figure

Reported vs recomputed ratio of RRs with 95% CIs for the three outcomes of Table 3; only the MI interval differs, and the printed MI interval ends below its own point estimate

Figure 1. Ratio of RRs of aspirin (diabetes vs no diabetes), with 95% CIs, on a log axis. For each outcome, the upper line (orange circle) is the value printed in the abstract and in Table 3's "pooled across trials" column. The lower line (blue square) is recomputed by recompute.py.txt from the Table 3 subgroup RRs using the paper's stated Altman–Bland method. The dashed vertical line marks a ratio of 1 (no difference). For mortality and ischemic stroke the two intervals coincide. For MI the printed interval (0.82–1.17) stops short of its own point estimate (1.19). The recomputed interval runs to 1.73. Both MI intervals include 1. The recomputed mortality point shows as 1.11 rather than 1.12 only because 1.1149 rounds down.

Why it matters

Explanations considered

Status

As of 2026-10-24.

Suggested correction

In the abstract (Results) and in Table 3 (myocardial infarction row, column "Ratio of RRs pooled across trials"), the 95% CI for the ratio of RRs should read approximately 0.82–1.73 in place of 0.82–1.17. That is the value the paper's stated Altman–Bland method gives from the Table 3 subgroup RRs. If the authors recompute from the unrounded estimates, or from the subtotals corrected in the 2018 erratum (which give 0.82–1.71), they should print their own figure. The point estimate (1.19) and the P interaction (0.36) need no change. The authors may also wish to state that the corrected interval, while still including 1, is compatible with a substantially smaller relative MI benefit of aspirin in patients with diabetes than the printed interval suggested.